BIOMAT Database Logo BIOMAT Database Logo

1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives. 1990

D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Department of Chemistry, ICI Pharmaceuticals, Mereside, Cheshire, U.K.

A series of 1,2,4-triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity, which incorporate (1S,2S)-2-amino-1,3-dicyclohexyl-1-hydroxypropane, statine (Sta), and (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy-pentanoic acid (ACHPA) transition-state mimetics, have been prepared. Structure-activity relationships for renin inhibitory activity in the series are consistent with the 2-[8-isobutyl-6-phenyl-1,2,4-triazolo[4,3-a]pyrazin-3-yl]-3-(3 pyridyl)propionic acid moiety 10b acting as a non-peptidic replacement for the P4-P2 (Pro-Phe-His) residues of the natural substrate angiotensinogen. Compounds 12m, 12o and 12q were potent inhibitors of partially purified human renin (IC50 values 1.7, 6.8, and 3.7 nM, respectively), and also effectively lowered blood pressure in anesthetized, sodium depleted marmosets following intravenous administration. On oral administration however, no blood pressure lowering activity could be detected, and absorption studies in bile duct cannulated rats indicate that this may be due primarily to poor oral absorption, rather than rapid biliary excretion. The reason for the observed poor oral activity is not clear, but it seems unlikely that poor aqueous solubility or metabolic instability to gut enzymes are rate-determining, and other factors such as high molecular weight may also be very important.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002143 Callitrichinae A subfamily in the family CEBIDAE that consists of four genera: CALLITHRIX (marmosets), CALLIMICO (Goeldi's monkey), LEONTOPITHECUS (lion tamarins), and SAGUINUS (long-tusked tamarins). The members of this family inhabit the tropical forests of South and Central America. Cebuella,Genus Mico,Leontocebus,Mico Genus,Callithricidae,Callitrichidae,Cebuellas,Genus, Mico,Mico, Genus
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 3.1 Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives.
January 1991, Journal of medicinal chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis and Antibacterial Activity of Novel Triazolo[4,3-a]pyrazine Derivatives.
November 2023, Molecules (Basel, Switzerland),
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis, biological activity and molecular modeling study of novel 1,2,4-triazolo[4,3-b][1,2,4,5]tetrazines and 1,2,4-triazolo[4,3-b][1,2,4]triazines.
April 2020, Scientific reports,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors.
January 2022, Frontiers in chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Design and synthesis of 5-alkoxy-[1,2,4]triazolo[4,3-a]quinoline derivatives with anticonvulsant activity.
March 2009, European journal of medicinal chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis and pharmacological activity of 1,2,4-triazolo[4,3-a]quinolines.
December 2001, Farmaco (Societa chimica italiana : 1989),
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Biological activity and a modified synthesis of 8-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycin.
July 1984, Journal of medicinal chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis and anticonvulsant activity of 8-alkoxy-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-1-one derivatives.
April 2011, European journal of medicinal chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents.
January 2013, ISRN organic chemistry,
D A Roberts, and R H Bradbury, and D Brown, and A Faull, and D Griffiths, and J S Major, and A A Oldham, and R J Pearce, and A H Ratcliffe, and J Revill
Synthesis and anticonvulsant activity of 1-formamide-triazolo[4,3-a]quinoline derivatives.
May 2010, Archives of pharmacal research,
Copied contents to your clipboard!